CRP and cancer: Forrest et al. [5] initially proposed the GPS, a composite of serum CRP and albumin levels, as a prognostic indicator for cancer patients, based on the concept that elevated CRP levels (cut-off, 1.0 mg/dl) or decreased albumin levels (cut-off, 3.5 mg/dl) may indicate an aggressive cancer progression.